Indicators

Markets:

News

Latest News about RYTM

Recent news which mentions RYTM

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session

April 06, 2022

40 Stocks Moving In Wednesday's Mid-Day Session

April 06, 2022

Rhythm Pharma Shares Fall After Modifications To Setmelanotide Trials In Rare Diseases of Obesity

April 06, 2022

Rhythm Pharmaceuticals Earnings Perspective: Return On Capital Employed

March 04, 2022

Rhythm Pharmaceuticals: Q4 Earnings Insights

March 01, 2022

Earnings Scheduled For March 1, 2022

March 01, 2022

Thinking About Buying Stock In Lucid Group, Rhythm Pharmaceuticals Or Kohl's?

February 28, 2022

A Preview Of Rhythm Pharmaceuticals's Earnings

February 28, 2022

Why Rhythm Pharmaceuticals Shares Are Falling Today

February 24, 2022

60 Biggest Movers From Yesterday

February 18, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

February 17, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022

February 17, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

February 17, 2022

Rhythm Pharma's Highlights Interim Setmelanotide Data In Long Term Genetic Disorder Trial

February 16, 2022

Stocks That Hit 52-Week Lows On Monday

February 14, 2022

52 Weeks High And Low Article

February 11, 2022

Stocks That Hit 52-Week Lows On Friday

February 04, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021

December 08, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021

November 19, 2021

Earnings Scheduled For November 2, 2021

November 02, 2021

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

October 12, 2021

Rhythm Pharma's Imcivree Wins UK Approval For Obesity, Hunger Control

September 22, 2021

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

September 09, 2021

Stocks That Hit 52-Week Lows On Friday

August 20, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

Stocks That Hit 52-Week Lows On Thursday

August 19, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

Stocks That Hit 52-Week Lows On Tuesday

August 17, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.